The relationship between adiponectin, ageing and renal function in a bi-ethnic sample
I M Kruger1, H W Huisman, A E Schutte
1Hypertension in Africa Research Team, North-West University, Private Bag X6001, Potchefstroom, 2520, South Africa.
Regulatory Peptides
|May 7, 2011
Summary
Age-related increases in adiponectin levels were observed in Africans but not Caucasians. Insulin resistance, not renal function, was most strongly associated with adiponectin in all groups.
Area of Science:
- Endocrinology
- Nephrology
- Gerontology
Background:
- Aging is linked to higher adiponectin levels.
- Adiponectin is an adipokine with roles in glucose and lipid metabolism.
- Its association with age-related changes in renal function requires further investigation.
Purpose of the Study:
- To investigate the relationship between aging, adiponectin levels, and renal function.
- To compare these associations across African and Caucasian men and women.
- To identify factors associated with elevated adiponectin in aging populations.
Main Methods:
- Cross-sectional study of African (N=277) and Caucasian (N=326) participants.
- Measurement of serum adiponectin, estimated creatinine clearance, and obesity indices.
- Statistical analyses including regression models to assess associations.
Main Results:
- African men had higher adiponectin than Caucasian men, despite lower adiposity.
- Adiponectin increased significantly with age in Africans but not Caucasians.
- Renal function declined with age in all groups.
- Insulin resistance showed the strongest association with adiponectin levels across all groups.
Conclusions:
- The age-related rise in adiponectin in Africans is likely not driven by declining renal function.
- Insulin resistance is a key determinant of adiponectin levels, irrespective of age or ethnicity.
- Further research is needed to elucidate the complex interplay between adiponectin, aging, ethnicity, and metabolic health.
Related Concept Videos
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...